newsfilter
← Latest News
Business Wire·

Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing

Landmark studies leverage Afirma GRID whole transcriptome-derived data to identify molecular classifiers and signatures differentiating thyroid cancer risk groups Veracyte, Inc. (NASDAQ:VCYT), a leading genomic